Status: Not yet recruiting
Use of Misoprostol in Hysteroscopic Myomectomy
Hysteroscopic myomectomy is typically suitable for myomas measuring under 4 cm in size. The utilization of misoprostol before the procedure can facilitate uterine access, decrease fluid absorption, and reduce blood loss, consequently leading to a decrease in the overall procedure time. In this randomized trial, the investigators aim to investigate the impact of misoprostol administration and its effects on each of the mentioned parameters.
Participants needed: 200
Trial details
Phase: Phase 4Age: 20-55Biological sex: FemaleType: InterventionalSponsor: Assuta Ashdod HospitalUpdated: Sep 22, 2023Locations: 1
Eligibility criteria
women between the ags of 20 years- 55 years, inclusive [+4]
post menopausal women [+6]